Pemetrexed Disodium Heptahydrate

Treat non-small cell lung cancer, malignant pleural mesothelioma, and solid tumors with Altico Biotech’s Pemetrexed Disodium Heptahydrate. A multi-targeted antifolate that inhibits DNA and RNA synthesis.

Description

Pemetrexed Disodium Heptahydrate is an important chemotherapy drug used in the treatment of various cancers, including non-small cell lung cancer (NSCLC), malignant pleural mesothelioma, and other solid tumors. As a multi-targeted antifolate, Pemetrexed works by inhibiting critical enzymes involved in DNA and RNA synthesis, which prevents cancer cells from proliferating and results in the death of these rapidly dividing cells.

Pemetrexed Disodium Heptahydrate specifically targets enzymes such as thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. By inhibiting these enzymes, Pemetrexed disrupts the formation of nucleotides required for DNA and RNA synthesis, thus slowing the growth of tumor cells and enhancing the effectiveness of cancer treatment.

Altico Biotech is a leading API raw material supplier and pharmaceutical raw materials manufacturer, specializing in delivering high-quality ingredients for pharmaceuticals, cosmetics, and health food industries. As a trusted cosmetic ingredients supplier, they provide organic raw materials for cosmetics, including herbal extracts for cosmetics, ensuring natural and sustainable formulations. Their portfolio includes active pharmaceutical ingredients (API), nutraceutical raw materials, and bulk health food raw materials, catering to the growing demand for health and wellness products. Altico Biotech is your reliable partner for innovative and high-grade natural health food ingredients and nutraceutical raw materials supplier solutions.

More Languages ยป